|

An International Study on Pediatric Patients With Rare Tumors.

RECRUITINGSponsored by Azienda Ospedaliera di Padova
Actively Recruiting
SponsorAzienda Ospedaliera di Padova
Started2025-01-25
Est. completion2049-01-06
Eligibility
Age0 Years – 18 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07072143

Summary

The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.

Eligibility

Age: 0 Years – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

* Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center.
* Written informed consent from the patient and/or the parent/legal guardian

Exclusion Criteria:

* Absence of Written informed consent from the patient and/or the parent/legal guardian

Conditions15

Adrenocortical TumorAppendiceal CancersCancerEsthesioneuroblastoma, OlfactoryGastrointestinal Stromal Tumor (GIST)Melanoma and Other Malignant Neoplasms of SkinMesotheliomaNUT CarcinomaNasopharyngeal Carcinoma (NPC)Pancreatic Tumors

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.